Allogeneic hematopoietic transplantation for indolent lymphomas: improved outcome with non-myeloablative versus high dose chemotherapy (HDCT) regimens

Issa Khouri, Rima Saliba, Sergio Giralt, Fredrick Hagemeister, Martin Korbling, Anas Younes, James Gajewski, Naoto Ueno, Paolo Anderlini, Fernando Cabanillas, Richard Champlin

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Allogeneic hematopoietic transplantation for indolent lymphomas: improved outcome with non-myeloablative versus high dose chemotherapy (HDCT) regimens'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds